- Home
- AQST vs BBNX Comparison
AQST vs BBNX Comparison
Compare AQST & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- BBNX
- Stock Information
- Founded
- AQST 2004
- BBNX 2015
- Country
- AQST United States
- BBNX United States
- Employees
- AQST N/A
- BBNX N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- BBNX Medical/Dental Instruments
- Sector
- AQST Health Care
- BBNX Health Care
- Exchange
- AQST Nasdaq
- BBNX Nasdaq
- Market Cap
- AQST 809.3M
- BBNX 967.6M
- IPO Year
- AQST 2018
- BBNX 2025
- Fundamental
- Price
- AQST $5.59
- BBNX $28.27
- Analyst Decision
- AQST Strong Buy
- BBNX Strong Buy
- Analyst Count
- AQST 7
- BBNX 11
- Target Price
- AQST $10.00
- BBNX $28.09
- AVG Volume (30 Days)
- AQST 3.0M
- BBNX 764.2K
- Earning Date
- AQST 11-05-2025
- BBNX 10-28-2025
- Dividend Yield
- AQST N/A
- BBNX N/A
- EPS Growth
- AQST N/A
- BBNX N/A
- EPS
- AQST N/A
- BBNX N/A
- Revenue
- AQST $43,397,000.00
- BBNX $88,570,000.00
- Revenue This Year
- AQST N/A
- BBNX $52.13
- Revenue Next Year
- AQST $51.39
- BBNX $36.07
- P/E Ratio
- AQST N/A
- BBNX N/A
- Revenue Growth
- AQST N/A
- BBNX 67.01
- 52 Week Low
- AQST $2.12
- BBNX $8.89
- 52 Week High
- AQST $7.55
- BBNX $30.47
- Technical
- Relative Strength Index (RSI)
- AQST 37.83
- BBNX 66.94
- Support Level
- AQST $5.44
- BBNX $24.33
- Resistance Level
- AQST $6.85
- BBNX $28.41
- Average True Range (ATR)
- AQST 0.42
- BBNX 2.09
- MACD
- AQST -0.20
- BBNX 0.28
- Stochastic Oscillator
- AQST 7.47
- BBNX 79.95
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.